1-Bromo-2-methylpropane

We are 1-Bromo-2-methylpropane CAS:78-77-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-Bromo-2-methylpropane
CAS.NO:78-77-3
Synonyms:1-Bromo-2-methylpropane
Propane,1-bromo-2-methyl-
Molecular Formula:C4H9Br
Molecular Weight:137.01800
 
Physical and Chemical Properties:
Density:1.26;
Melting point:-119oC;
Boiling point:90-92oC;
Flash point:65oC;
Index of Refraction:1.435;
 
Specification:
Appearance:Colorless Clear Liquid
Purity(GC):≥99.0%
Moisture:≤0.05%
pH:6.0-7.0
 
Packing:250 kg/drum, can also be packaged according to customer requirements
Synthesis:The product is obtained by reacting isobutanol with hydrobromic acid or sodium bromide
Application:For organic synthesis intermediates
 

1-Bromo-2-methylpropane


Related News: Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets.(S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenyipropanoic acid CAS:868540-16-3 Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets.80841-78-7 According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter.3-Aminopropanol “With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”“With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”

Related Products
Product Name
Triacetonamine View Details
3-(Trifluoromethoxy)benzoyl chloride View Details
2,6-Difluorobenzyl chloride View Details
4-Bromo-2-methylbenzoic acid manufacturer 2,2,3,3-tetrafluorooxetane Cas:765-63-9 manufacturer 4-Bromotoluene manufacturer 2-bromo-5-methylpyridin-3-amine manufacturer (R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole manufacturer